Biofire mycoplasma assay reagents

Ended Purchase Order Awarded Last action

Contract number
75N90023P00652
Awardee
Awarding agency
Obligated
$24,663

Award facts

Contract value 100% obligated
$24,663.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$237
Original award $24,900

About this award

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,663 purchase order to Biomerieux Inc. for BIOFIRE MYCOPLASMA ASSAY REAGENTS. The contract has a period of performance from July 27, 2023 through December 7, 2023 and utilizes a firm fixed price payment structure. Biomerieux Inc. will provide assay reagents to support diagnostic testing needs at the NIH Clinical Center in Bethesda, Maryland. No subcontractors or set aside designations were indicated. The award assists the NIH Clinical Center, part of the NIH focused on clinical research and patient care, in evaluating patients for potential mycoplasma infections through laboratory diagnostic testing.

Quick answers

Who was awarded contract 75N90023P00652?

75N90023P00652 was awarded to Biomerieux Inc. by NIH Clinical Center (National Institutes of Health) on July 27, 2023.

How much is contract 75N90023P00652 worth?

The government has obligated $24,663 on 75N90023P00652.

Was contract 75N90023P00652 competed?

The extent of competition for 75N90023P00652 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award